M. Veeranarayana Reddy et al. / Tetrahedron 68 (2012) 6820e6828
6827
(hexane/ethyl acetate (3:1)); Yield 90%; yellow powder; mp
127.4, 126.6, 117.3, 113.9, 63.8, 62.9, 50.2, 37.2, 34.2, 28.0, 27.8,
14.6 ppm. HRMS (ESI, m/z): calcd for C25H24F2N2O4 (MþHþ)
416.1736; found: 416.1730.
265e267 ꢀC. IR (KBr):
n
¼2956, 2863, 1652, 1350, 1312 cm-1 1H NMR
(400 MHz, CDCl3):
d 8.37e8.34 (m, 1H), 8.26e8.20 (m, 1H),
7.80e7.88 (m, 2H), 7.22e7.19 (m, 1H), 7.13e7.10 (m, 2H), 6.57 (s, 1H),
3.41 and 3.23 (AB System, J¼19.4 Hz, 2H), 2.34 (s, 2H), 1.22 (s, 3H),
4.2.14. 3,4-Dihydro-13-(2-hydroxyphenyl)-3,3-dimethyl-2H-in-
dazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4n). Rf value¼0.56
(hexane/ethyl acetate (3:1)); Yield 92%; yellow powder; mp
1.19 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3):
d 191.3, 155.4, 153.8,
134.0, 133.2, 131.9, 128.4, 128.0, 127.5, 126.8, 125.8, 125.2, 123.8,
116.9, 116.4, 115.7, 59.3, 50.1, 37.3, 34.0, 28.2, 27.5. HRMS (ESI, m/z):
calcd for C23H18F2N2O3 (MþHþ) 408.1285; found: 408.1282.
188e190 ꢀC. IR (KBr):
(400 MHz, CDCl3):
n
¼2971, 2865, 1644, 1365, 1229 cm-1 1H NMR
d
11.5 (s, 1H), 8.03e8.01 (m, 2H), 7.85e7.81 (m,
2H), 7.06e7.02 (m, 1H), 6.95e6.89 (m, 3H), 3.42 and 3.22 (AB Sys-
tem, J¼19.1 Hz, 2H), 2.30 (s, 2H), 1.28 (t, J¼6.8 Hz, 3H), 1.17 (s, 6H)
4.2.9. 13-(2,4-Difluorophenyl)-3,4-dihydro-3,3-dimethyl-2H-in-
dazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4i). Rf value¼0.59
(hexane/ethyl acetate (3:1)); Yield 90%; yellow powder; mp
ppm. 13C NMR (100 MHz, CDCl3):
d 195.7, 155.1, 154.0, 149.6, 132.5,
128.3, 126.8, 125.6, 125.1, 124.1, 120.3, 115.2, 111.2, 62.3, 50.4, 38.8,
31.5, 28.1, 27.5 ppm. HRMS (ESI, m/z): calcd for C23H20F2N2O4
(MþHþ) 388.1423; found: 388.1420.
266e268 ꢀC. IR (KBr):
(400 MHz, CDCl3):
n
¼2956, 2865, 1660, 1357, 1304 cm-1 1H NMR
d 8.37e8.34 (m, 1H), 8.26e8.24 (m, 1H),
7.87e7.84 (m, 2H), 7.50e7.45 (m, 1H), 6.91e6.88 (m, 1H), 6.77e6.74
(m, 1H), 6.50 (s, 1H), 3.41 and 3.21 (AB System, J¼19.0 Hz, 2H), 2.33
(s, 2H), 1.21 (s, 3H), 1.19 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3):
4.2.15. 3,4-Dihydro-3,3-dimethyl-13-(pyridin-2-yl)-2H-indazolo[2,1-
b]phthalazine-1,6,11(13H)-trione (4o). Rf value¼0.56 (hexane/ethyl
acetate (3:1)); Yield 90%; yellow powder; mp 229e231 ꢀC
d
193.3, 156.1, 154.4, 151.7, 134.5, 133.6, 131.7, 130.2, 129.1, 128.9,
(230e232 ꢀC).24 1H NMR (400 MHz, CDCl3):
d 8.36e8.30 (m, 2H),
128.0, 127.6, 121.0, 116.6, 112.1, 111.8, 104.7, 60.8, 50.8, 37.9, 34.6,
28.8, 28.0 ppm. HRMS (ESI, m/z): calcd for C23H18F2N2O3 (MþHþ)
408.1285; found: 408.1285.
8.04 (d, J¼8.4 Hz, 1H), 7.87e7.84 (m, 2H), 7.66e7.50 (m, 3H), 6.40 (s,
1H), 3.40 and 3.21 (AB System, J¼19.1 Hz, 2H), 2.30 (s, 2H), 1.19 (s,
6H) ppm. 13C NMR (100 MHz, CDCl3):
d 192.1, 156.2, 154.3, 151.6,
148.6, 138.6, 134.4, 133.4, 129.3, 128.2, 127.8, 123.8, 119.4, 115.4, 60.0,
50.9, 38.4, 31.2, 28.8, 28.4 ppm.
4.2.10. 13-(3,4-Difluorophenyl)-3,4-dihydro-3,3-dimethyl-2H-in-
dazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4j). Rf value¼0.65
(hexane/ethyl acetate (3:1)); Yield 91%; yellow powder; mp
206e208 ꢀC. IR (KBr):
n
¼2956, 2855, 1667, 1357, 1266 cm-1 1H NMR
4.2.16. 3,4-Dihydro-13-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3,3-
dimethyl-2H-indazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4p). Rf
value¼0.62 (hexane/ethyl acetate (3:1)); Yield 90%; yellow powder;
(400 MHz, CDCl3):
d 8.36e8.34 (m, 1H), 8.27e8.25 (m, 1H),
7.87e7.85 (m, 2H), 7.23e7.11 (m, 3H), 6.39 (s, 1H), 3.39 and 3.23 (AB
mp 254e256 ꢀC. IR (KBr):
n
¼2956, 2880, 1660, 1349, 1289 cm-1 1
H
System, J¼19.1 Hz, 2H), 2.34 (s, 2H), 1.20 (s, 6H) ppm. 13C NMR
NMR (400 MHz, CDCl3):
d 8.34e8.32 (m, 1H), 8.28e8.26 (m, 1H),
(100 MHz, CDCl3):
d 192.0, 155.9, 154.5, 151.2, 134.7, 133.7, 133.4,
7.84e7.82 (m, 2H), 6.95 (d, J¼8.2 Hz,1H), 6.82 (d, J¼9.2 Hz, 2H), 6.34
(s, 1H), 4.19 (s, 4H), 3.39 and 3.22 (AB System, J¼19.1 Hz, 2H), 2.33
(s, 2H), 1.22 (s, 3H), 1.19 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3):
128.9, 128.8, 128.1, 127.7, 123.8, 117.6, 117.4, 116.3, 63.9, 50.8, 38.0,
34.6, 28.6, 28.4 ppm. HRMS (ESI, m/z): calcd for C23H18F2N2O3
(MþHþ) 408.1285; found: 408.1285.
d
192.1, 155.9, 154.2, 150.6, 143.8, 134.4, 133.4, 129.5, 129.1, 128.9,
127.9, 127.6, 120.7, 118.4, 117.4, 115.7, 64.4, 64.1, 50.9, 37.9, 34.6,
28.5 ppm. HRMS (ESI, m/z): calcd for C25H22N2O5 (MþHþ)
430.1529; found: 430.1528.
4.2.11. 13-(3,5-Difluorophenyl)-3,4-dihydro-3,3-dimethyl-2H-in-
dazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4k). Rf value¼0.58
(hexane/ethyl acetate (3:1)); Yield 92%; yellow powder; mp
230e232 ꢀC. IR (KBr):
n
¼2971, 2865, 1652, 1357, 1305 cm-1 1H NMR
4.2.17. 13-(Benzo[d][1,3]dioxol-5-yl)-3,4-dihydro-3,3-dimethyl-2H-
indazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4q). Rf value¼0.61
(hexane/ethyl acetate (3:1)); Yield 91%; yellow powder; mp
(400 MHz, CDCl3):
d 8.37e8.35 (m, 1H), 8.28e8.26 (m, 1H),
7.88e7.86 (m, 2H), 6.95 (d, J¼7.2 Hz, 2H), 6.74e6.69 (m, 1H), 6.39 (s,
1H), 3.38 and 3.23 (AB System, J¼19.1 Hz, 2H), 2.34 (s, 2H), 1.20 (s,
258e260 ꢀC. IR (KBr):
(400 MHz, CDCl3):
n
¼2956, 2880, 1660, 1364, 1312 cm-1 1H NMR
6H) ppm. 13C NMR (100 MHz, CDCl3):
d 191.9, 164.2, 155.9, 154.5,
d 8.36e8.33 (m, 1H), 8.26e8.23 (m, 1H),
151.4, 140.3, 134.7, 133.8, 128.9, 128.1, 127.7, 117.4, 110.4, 104.4, 103.9,
63.9, 50.8, 38.0, 34.6, 28.6, 28.4 ppm. HRMS (ESI, m/z): calcd for
C23H18F2N2O3 (MþHþ) 408.1285; found: 408.1284.
7.88e7.84 (m, 2H), 6.88e6.75 (m, 3H), 6.32 (s, 1H), 5.93 (s, 2H), 3.40
and 3.22 (AB System, J¼19.2 Hz, 2H), 2.32 (s, 2H), 1.21 (s, 6H) ppm.
13C NMR (100 MHz, CDCl3):
d 193.0, 156.9, 152.0, 148.4, 145.3, 137.5,
135.6, 133.5, 129.6, 128.9, 128.1, 121.6, 115.6, 114.5, 106.7, 102.3, 65.0,
51.3, 35.4, 33.9, 28.0, 27.8 ppm. HRMS (ESI, m/z): calcd for
C24H20N2O5 (MþHþ) 416.1372; found: 416.1374.
4.2.12. 3,4-Dihydro-13-(3,4,5-trimethoxyphenyl)-3,3-dimethyl-2H-
indazolo[2,1-b]phthalazine-1,6,11(13H)-trione (4l). Rf value¼0.60
(hexane/ethyl acetate (3:1)); Yield 90%; yellow powder; mp
235e237 ꢀC (233e235 ꢀC).231H NMR (CDCl3, 400 MHz)
d 8.30e8.22
4.2.18. 3,4-Dihydro-3,3-dimethyl-13-(thiophen-3-yl)-2H-indazolo
[2,1-b]phthalazine-1,6,11(13H)-trione (4r). Rf value¼0.59 (hexane/
ethyl acetate (3:1)); Yield 90%; yellow powder; mp 218e220 ꢀC
(m, 2H), 7.89e7.87 (m, 2H), 6.60 (s, 2H), 6.45 (s, 1H), 3.83 (s, 9H),
3.42 and 3.21 (AB System, J¼19.1 Hz, 2H), 2.33 (s, 2H), 1.24 (s, 6H)
ppm. 13C NMR(CDCl3, 100 MHz)
d 192.0, 156.3, 154.6, 153.0, 150.8,
(217e219 ꢀC).24 1H NMR (CDCl3, 400 MHz):
d 8.30e8.25 (m, 2H),
138.6, 134.3, 133.3, 131.3, 129.0, 128.4, 128.0, 127.5, 118.3, 104.3, 65.6,
60.3, 56.9, 50.9, 38.0, 34.6, 28.9, 28.1 ppm.
7.85e7.82 (m, 2H), 7.30 (s, 1H), 7.23e7.22 (m, 1H), 6.95e6.93 (m,
1H), 6.52 (s, 1H), 3.41 and 3.22 (AB System, J¼19.1 Hz, 2H), 2.31 (s,
2H), 1.22 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3):
d 192.0, 154.2,
4.2.13. 13-(4-Ethoxyphenyl)-3,4-dihydro-3,3-dimethyl-2H-indazolo
[2,1-b]phthalazine-1,6,11(13H)-trione (4m). Rf value¼0.60 (hexane/
ethyl acetate (3:1)); Yield 93%; yellow powder; mp 178e180 ꢀC. IR
150.5, 138.6, 134.3, 133.5, 129.0, 128.8, 128.1, 127.9, 127.2, 125.8,
117.3, 60.2, 50.2, 37.8, 34.3, 28.9, 28.0 ppm.
(KBr):
CDCl3):
n
¼2971, 2850, 1652, 1349, 1312 cm-1 1H NMR (400 MHz,
4.2.19. 13-Ethyl-3,4-dihydro-3,3-dimethyl-2H-indazolo[2,1-b]phtha-
lazine-1,6,11(13H)-trione (4s). Rf value¼0.61 (hexane/ethyl acetate
(3:1)); Yield 80%; yellow powder; mp 146e148 ꢀC (145e147 ꢀC).23
d
8.24e8.22 (m, 1H), 8.09e8.09 (m, 1H), 7.95e7.92 (m, 2H),
7.32 (d, J¼8.8 Hz, 2H), 6.83 (d, J¼8.5 Hz, 2H), 6.22 (s, 1H), 4.00e3.94
(m, 2H), 3.32 and 3.15 (AB System, J¼19.2 Hz, 2H), 2.25 (s, 2H), 1.28
(t, J¼6.8 Hz, 3H), 1.19 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3):
1H NMR (400 MHz, CDCl3):
d
8.30e8.33 (m, 1H), 8.26e8.23 (m,
1H), 7.88e7.84 (m, 2H), 5.70e5.68 (m, 1H), 3.40 and 3.22 (AB
d
191.8, 158.2, 155.3, 154.0, 151.0, 134.4, 133.6, 129.2, 128.9, 128.7,